Zisser Howard C, Bevier Wendy, Dassau Eyal, Jovanovic Lois
Sansum Diabetes Research Institute, Santa Barbara, California 93105, USA.
J Diabetes Sci Technol. 2010 Jan 1;4(1):98-103. doi: 10.1177/193229681000400112.
The objective was to quantify hydrostatic effects on continuous subcutaneous insulin infusion (CSII) pumps during basal and bolus insulin delivery.
We tested CSII pumps from Medtronic Diabetes (MiniMed 512 and 515), Smiths Medical (Deltec Cozmo 1700), and Insulet (OmniPod) using insulin aspart (Novolog, Novo Nordisk). Pumps were filled and primed per manufacturer's instructions. The fluid level change was measured using an inline graduated glass pipette (100 microl) when the pipette was moved in relation to the pump (80 cm Cosmo and 110 cm Medtronics) and when level. Pumps were compared during 1 and 5 U boluses and basal insulin delivery of 1.0 and 1.5 U/h.
Pronounced differences were seen during basal delivery in pumps using 80-100 cm tubing. For the 1 U/h rate, differences ranged from 74.5% of the expected delivery when the pumps were below the pipettes and pumping upward to 123.3% when the pumps were above the pipettes and pumping downward. For the 1.5 U/h rate, differences ranged from 86.7% to 117.0% when the pumps were below or above the pipettes, respectively. Compared to pumps with tubing, OmniPod performed with significantly less variation in insulin delivery.
Changing position of a conventional CSII pump in relation to its tubing results in significant changes in insulin delivery. The siphon effect in the tubing may affect the accuracy of insulin delivery, especially during low basal rates. This effect has been reported when syringe pumps were moved in relation to infusion sites but has not been reported with CSII pumps.
目的是量化基础胰岛素输注和大剂量胰岛素输注期间,静水压对持续皮下胰岛素输注(CSII)泵的影响。
我们使用门冬胰岛素(诺和锐,诺和诺德公司)对美敦力糖尿病公司(MiniMed 512和515)、史密斯医疗公司(德尔泰科兹莫1700)和英素力特公司(OmniPod)的CSII泵进行了测试。按照各制造商的说明对泵进行填充和预充。当移液管相对于泵移动(科兹莫为80厘米,美敦力为110厘米)以及处于水平状态时,使用在线刻度玻璃移液管(100微升)测量液位变化。在1单位和5单位大剂量胰岛素输注以及1.0和1.5单位/小时的基础胰岛素输注期间对泵进行比较。
在使用80 - 100厘米管路的泵进行基础输注期间观察到明显差异。对于1单位/小时的输注速率,当泵位于移液管下方并向上泵送时,差异范围为预期输注量的74.5%,而当泵位于移液管上方并向下泵送时,差异范围为123.3%。对于1.5单位/小时的输注速率,当泵位于移液管下方或上方时,差异范围分别为86.7%至117.0%。与带管路的泵相比,OmniPod在胰岛素输注方面的变化明显较小。
传统CSII泵相对于其管路位置的改变会导致胰岛素输注的显著变化。管路中的虹吸效应可能会影响胰岛素输注的准确性,尤其是在低基础输注速率期间。当注射泵相对于输注部位移动时曾有过这种效应的报道,但CSII泵尚未见相关报道。